Septic Shock clinical trials at UCLA

1 research study open to eligible people

Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study
open to eligible people ages 18 years and up
Prospective, multicenter, randomized, open-label study of standard of care plus the PMX cartridge versus standard of care alone in patients with endotoxemic septic shock
Los Angeles, California and other locations

Last updated: February 11, 2025